UroGen Pharma Ltd.URGNNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-95.35M
↓ 44% below average
Average (9y)
$-66.25M
Historical baseline
Range
High:$1.01M
Low:$-122.71M
CAGR
+25.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-95.35M | -58.0% |
| 2023 | $-60.35M | +20.8% |
| 2022 | $-76.21M | +16.7% |
| 2021 | $-91.46M | +25.5% |
| 2020 | $-122.71M | -13.5% |
| 2019 | $-108.15M | -40.1% |
| 2018 | $-77.18M | -290.9% |
| 2017 | $-19.74M | -2052.8% |
| 2016 | $1.01M | +108.2% |
| 2015 | $-12.30M | - |